I edit Evidence-based Oncology section in Cancer Treatment Reviews. Our approach was to select journals impact factor =>3 (related to cancer field). This list was then sent to 6 oncologists who approved the list (+ added a couple more titles totaling to about 100 titles).
Ben Djulbegovic
-----Original Message-----
From: Paul Glasziou [mailto:[log in to unmask]]
Sent: Wednesday, May 26, 2004 9:43 AM
To: [log in to unmask]
Subject: Re: Core Journals
Jon,
It depends a little on what you are after - research articles, news, etc
If its just the clinical relevant research articles then the ACPJC/EBM
process has been to screen for validity and then get votes by clinicians
for relevance. An analysis of the frequency of articles from over 100
journals showed that the majority of studies that should change practice
came from a few general journals. (So one caveat about "speciality"
journals is that major studies, even for specialities, will be covered by
NEJM, Lancet, JAMA, BMJ, Annals Int Med and Cochrane.) Ideally you'd
repeat this process for each speciality.
Paul Glasziou
At 26/05/2004, Jon Brassey wrote:
>If one wanted to identify the 10-15 core journals in a given clinical
>speciality (e.g. child health, genetics) any ideas how to go about it?
>
>I have thought of a couple of ways. Firstly, ask a group of clinicians
>who specialise in that area and ask them to nominate the journals they
>consider core. Secondly, use the impact factor of each journal in the
>speciality and pick the top 10-15 using that. I don't consider either ideal!
>
>Also where can you obtain the impact factors for each journal?
>
>Best wishes
>
>Jon
>
>
>-----------------------------------------
>Email provided by http://www.ntlhome.com/
Paul Glasziou
Department of Primary Health Care &
Director, Centre for Evidence-Based Practice, Oxford
ph: 44-1865-227055 www.cebm.net
######################################################################
This transmission may be confidential or protected from disclosure and
is only for review and use by the intended recipient. Access by
anyone else is unauthorized. Any unauthorized reader is hereby
notified that any review, use, dissemination, disclosure or copying of
this information, or any act or omission taken in reliance on it, is
prohibited and may be unlawful. If you received this transmission in
error, please notify the sender immediately. Thank you.
######################################################################
|